期刊文献+

对氧磷酶-1活性与冠状动脉病变支数的相关性研究 被引量:1

RELATIONSHIP OF PARAOXONASE-1 ACTIVITY AND NUMBER OF STENOSED CORONARY ARTERY LESIONS VESSELS
下载PDF
导出
摘要 目的探讨血清对氧磷酶-1(PON-1)活性与冠状动脉病变支数的关系。方法212例按冠状动脉造影结果分为冠状动脉狭窄(CHD+)组(151例)和冠状动脉正常(CHD-)组(61例),并根据冠状动脉病变程度将CHD+组分为单支病变组(34例),双支病变组(46例),三支病变组(71例)。分光光度法测定血清PON-1活性;分析PON-1活性与冠状动脉病变支数的关系。结果冠心病组血清PON-1活性明显低于对照组(t=17.25,P<0.0001);血清PON-1活性单支病变组明显高于双支、三支病变组(F=9.536,P<0.05);而双支和三支病变组比较差异无统计学意义(P=0.13)。结论冠心病患者血清PON-1活性水平明显降低,随着病变程度加重,血清PON-1活性水平降低。 Objective To explore the relationship of activity of paraoxonase-1(PON- 1) in coronary artery disease and the number of stenosed coronary artery lesions vessels in coronary artery disease (CAD) patients. Methods 212 subjects were investigated in this study , including 61 healthy subjects,151 cases who were confirmed as CAD by coronary angiography, including stable angina, old myocardial infarction, unstable angina. CAD cases were divided into single vessel (n = 34), double vessel (n=46) and triple vessel (n= 71) group. The activity of PON- 1 were determined by spectro photometry. Results The activity of PON- 1 were lower in CAD group than those in non- CAD group(t = 17.25, P〈0. 001). The relationship between the activity of PON- 1 and involved branch numbers of coronary arteries had statistically relationship (F = 9. 356, P〈0.05). The activity of PON- 1 were higher in single branch group than those in double and three branch group (P〈0. 05). But there is no significant difference between two branch group and three branch group(P = 0.13). Conclusion The study shows that the activity of PON - 1 is lower in CAD group than that in non- CAD group. The relationship between activity of PON- 1 and severity of the coronary artery atherosclerosis lesions has negative correlation.
出处 《中国煤炭工业医学杂志》 2006年第11期1126-1127,共2页 Chinese Journal of Coal Industry Medicine
基金 河北省科学技术厅资助项目(No.0427610D-43)
关键词 对氧磷酶-1 冠状动脉疾病 冠状动脉造影术 GENSINI积分 paraoxonase(PON- 1) coronary artery disease coronary angiography gensini score
  • 相关文献

参考文献15

  • 1Ayub A, Mackness MI, Arrol S, et al. Serum paraoxonase after myocardial infaretion[J]. Arterioseler Thromb Vase Biol, 1999,19(2) ,330- 335
  • 2杜玮南,温进坤,韩梅.人血清对氧磷酶活性测定方法的建立及临床初步应用[J].河北医科大学学报,1999,20(3):134-136. 被引量:22
  • 3Gensini GG. A more meaningful scoring system for detemining the severity of coronary heart disease[J]. Am J Cardiol, 1983,51(5) :606
  • 4Aviram M, Rosenblat M, Bisgainer CL, et al. Paraoxonase inhibits high density lipoprotein oxidation and preserves its function.A possible peroxidative role for paraoxonase[J]. J Clin Invest,1998,101(8) :1581 1590
  • 5Watson AD, Berliner JA, Hama SY, et al. Protective effect of HDL associated paraoxonase inhibition of the biological activity of minimally oxidized low density lipoprotein[J]]. J Clin Invest,1995,96(10) :2882 - 2891
  • 6宁江海,王玉霞,王青定,池木根,孙曼霁.人血清对氧磷酶的部分纯化及解毒效应[J].中国药理学与毒理学杂志,2002,16(1):60-65. 被引量:17
  • 7徐海.动脉粥样硬化的发生机制[M]//吴立玲.心血管病理生理学.北京:北京医科大学出版社,2000:1—12
  • 8Blatter MC, Abbott C, Messmer S,et al. Quantitation of human paraoxonase by enzyme- linked immunoassay: population defference in protein concentrations[J]. Biochem J, 1994, 304(5):549- 554
  • 9Navab M, Hama SY, Hough GP,et al. High density enzymes:their role in vascular biology[J]. Curr Opin Lipid, 1998, 9 (4):449 - 456
  • 10Mackness MI, Mackness B, Duringron PN, et al. Paraoxonase and coronary heart disease[J]. Curr Opin Lipid, 1998,9(3) :319- 324

二级参考文献20

  • 1Xiao MZ Wang WX.-[J].中国药理学与毒理学杂志,1990,4(2):146-150.
  • 2Mu SF Xiao MZ.-[J].生物化学杂志,1994,10(3):313-317.
  • 3Zhu MC.-[J].军事医学科学院院刊,1991,15(2):143-145.
  • 4Wang QD Su MJ.-[J].生物化学与生物物理进展,1996,23(3):217-221.
  • 5Xiao MZ Wang WX.-[J].军事医学科学院院刊,1989,13(4):358-360.
  • 6[1]Mackmess MI, MackmessB, DurringtonPN, etal. Paraosonase: biochemistry,genetics and relationship to plasma lipoproteins. Curr Opin Lipidol, 1996, 7:69-76
  • 7[2]Shih DM, Gu L, Xia YR, et al. Mice laking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature, 1998, 394:284-287
  • 8[3]AyubA, Mackness MJ, ArrolS, etal. Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol, 1999, 19:330-335
  • 9[4]Mackness B, Harty D, Bhatnagar D, et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin dependent diabetes mellitus. Atherosclerosis, 1991, 86:193-199
  • 10[5]Gan KN, Smolen A, Eckerson HW, et al. Purification of human serum paraoxonase /arylesterase. Drug Metab dispos, 1991, 19:100-106

共引文献71

同被引文献33

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部